Inhalant Intoxication

A. Recent intentional use or short-term, high-dose exposure to volatile inhalants (excluding anesthetic gases and short-acting vasodilators). 

B. Clinically significant maladaptive behavioral or psychological changes (e.g., belligerence, assaultiveness, apathy, impaired judgment, impaired social or occupational functioning) that developed during, or shortly after, use of or exposure to volatile inhalants. 

C. Two (or more) of the following signs, developing during, or shortly after, inhalant use or exposure: 

(1) dizziness 
(2) nystagmus 
(3) incoordination 
(4) slurred speech 
(5) unsteady gait 
(6) lethargy 
(7) depressed reflexes 
(8) psychomotor retardation 
(9) tremor 
(10) generalized muscle weakness 
(11) blurred vision or diplopia 
(12) stupor or coma 
(13) euphoria

D. The symptoms are not due to a general medical condition and are not better accounted for by another mental disorder.

Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Copyright 2000 American Psychiatric Association